Company Elects Pharmacy Industry Veteran Alan B. Levin to Board

Morrisville, N.C. - August 8, 2007 - Centice Corporation, a pioneer in next generation sensor technology, today announced that veteran pharmacy industry executive Alan B. Levin has been named to its board.

Mr. Levin was formerly Chairman, President and CEO of Happy Harry’s, a leading regional drugstore chain with 2,700 employees and stores in Delaware, Maryland, Pennsylvania and New Jersey, until it was acquired by the Walgreen Company in 2006.

“Alan is one of the most respected and talented executives in the pharmacy industry, and we are thrilled to have him join the board”, commented Ray W. Swanson, Centice’s President and CEO. “His knowledge of the pharmacy industry, along with his experience at leading and growing a successful company, will be invaluable as we pursue new growth opportunities for Centice”, Mr. Swanson added.

Mr. Levin commented, “I am very excited to join the Centice board at an extraordinary time in the company’s evolution. I look forward to assisting the board and management team to further position the company for long-term success.”

Alan Levin is a graduate of Tulane University and the Delaware Law School of Widener University. He previously served in the Delaware Department of Justice as a Deputy Attorney General and as Executive Assistant and Counsel to United States Senator William V. Roth, Jr. He assumed the position of Chairman, President and Chief Executive Officer of Happy Harry’s, when his father and founder of the business, Harry Levin, passed away in 1987. During his tenure the company grew from 19 to 76 stores. Mr. Levin is also a past Chairman of the National Association of Chain Drug stores.

About Centice
Centice, founded in 2004, is commercializing patent-pending computational sensor technology originally developed at Duke University. The PASS Rx™ pharmaceutical authentication sensor system is the Company’s first product. The Pass Rx™ system has the potential to improve the quality of dispensed medications, thereby increasing patient safety, and is anticipated for market availability in 2008. The company has received venture capital investments from The Aurora Funds, Inc. and Novak Biddle Venture Partners. More information on Centice can be found at http://www.centice.com.

Company Contact

Stacy Stein, Sales & Marketing
Phone: (919) 653-0424   sstein@centice.com